Patient population
The study included male and female patients (≥18 yr) with elevated ALT (males ≥43 U lRace was self-reported by the patient and captured on the demography electronic case report form.Key exclusion criteria were previous exposure to any FXR agonist (including tropifexor), current use or history of alcohol consumption (females >20 g d